To the Editor: We read with interest the report of 12 hospital presentations related to the use of naltrexone implants.1 The accompanying editorial highlights how the rigorous scrutiny required to evaluate the efficacy and safety of this procedure is lacking.2 Regrettably, this study is likely to distort rather than inform the debate.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.